Mobile App Therapy for Anxiety, Depression, and Bipolar Disorder
This study is testing two versions of a mobile app called MAYA to help young adults (ages 18-25) with anxiety, depression, or bipolar disorder. One version, the Personalized MAYA Mobile App, focuses on skills tailored to your specific symptoms and introduces new material over the first four weeks. The other, the General MAYA Mobile App, introduces new skills over the full six weeks. Researchers want to see if the personalized app is just as good at reducing anxiety and depression symptoms. Success will be measured by changes in your anxiety and depression scores. The study plans to enroll 100 participants, but its current recruitment status is unclear.
- Study design
- This interventional study will randomly assign participants to one of two versions of the MAYA app. It aims to enroll 100 participants.
- What's involved
- You would use the Maya app for two days per week, at least 20 minutes per day, for six weeks. You will also have weekly check-ins, complete questionnaires, and may have optional EEG recordings at the beginning and end of the intervention.
- Compensation
- Not stated in the trial record.
- Follow-up
- You will have a follow-up assessment at week 12, after the 6-week intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Personalized Mobile Cognitive Behavioral Therapy Application
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Jennifer Bress, Ph.D. · PRINCIPAL_INVESTIGATOR · Weill Medical College of Cornell University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change in anxiety symptoms from pre-intervention to post-intervention as measured by the HAM-A.Baseline to endpoint [Week 6]
The primary symptom measure for anxiety will be the Hamilton Rating Scale for Anxiety (HAM-A). The HAM-A is a 14-item questionnaire measure of the severity of anxiety symptoms. The items measure both psychic anxiety and somatic anxiety. The scores range from 0 to 56, where higher scores indicate a greater severity of symptoms and lower scores indicate mild to no anxiety symptoms.
- Change in depressive symptoms from pre-intervention to post-intervention as measured by HAM-D.Baseline to endpoint [Week 6]
The primary symptom measure for depression will be the Hamilton Rating Scale for Depression (HAM-D). The HAM-D is a 24-item questionnaire measuring the severity of depression symptoms. The scale ranges from 0 to 76, where higher scores indicate higher severity of depressive symptoms.
- Change in anxiety symptoms from pre-intervention to post-intervention as measured by the anxiety subscale of the DASS.Baseline to endpoint [Week 6]
Anxiety will be measured by the anxiety subscale of the Depression Anxiety Stress Scale (DASS). The anxiety subscale measures of the severity of anxiety symptoms. The scores range from 0 to 42, where higher scores indicate a greater severity of symptoms and lower scores indicate mild to no anxiety symptoms.
- Change in depressive symptoms from pre-intervention to post-intervention as measured by the depression subscale of the DASS.Baseline to endpoint [Week 6]
Depression will be measured by the depression subscale of the Depression Anxiety Stress Scale (DASS). The subscale measures of the severity of depressive symptoms. The scores range from 0 to 42, where higher scores indicate a greater severity of symptoms and lower scores indicate mild to no symptoms.